Latest filing published 07 Mar 2023 for Sutro Biopharma, INC..
Insider track record
No signal scores available.
Anik Shabbir: trading record in brief
All filings by Anik Shabbir on record concern Sutro Biopharma, Inc. Over a trading history stretching from 26 September 2019 to 3 March 2023, the count stands at 9 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 7 March 2023, the filings show an option exercise in Sutro Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anik Shabbir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,875 sharesCommon StockSEC:0001209191-23-016739:0
- 4,500 shares0Common StockSEC:0001209191-23-005754:0
- 8,750 sharesCommon StockSEC:0001209191-22-016850:0
- 4,500 shares0Common StockSEC:0001209191-22-006121:0
- 8,609 shares0Common StockSEC:0001209191-21-057976:0
- 8,609 shares0Common StockSEC:0001209191-20-052244:0
- 2,976 shares@ US$10.3049.7% of flowCommon StockSEC:0001209191-20-052244:1
- 8,608 shares0Common StockSEC:0001209191-19-051117:0
- 2,976 shares@ US$9.74Common StockSEC:0001209191-19-051117:1
9 of 9 declarations
